For more than five decades, World Health Expo has mirrored the transformation of both the global healthcare industry and the city that hosts it. What began as a modest regional exhibition has evolved into one of the world’s most influential healthcare convening platforms, bringing together policymakers, clinicians, innovators, manufacturers, investors and regulators from across continents.

According to Peter Hall, president for the Middle East, India, Türkiye and Africa at Informa Markets, the event’s 50-year milestone is inseparable from Dubai’s rise as a global healthcare and innovation hub.

“World Health Expo (WHX) was founded more than 50 years ago with a very simple but powerful vision from Sheikh Rashid bin Saeed Al Maktoum,” Hall says. “It began in a tent on the banks of Dubai Creek, with the aim of introducing international medical devices to the UAE and the wider region.”

From those beginnings, the event, formerly known as Arab Health, has grown into what Hall describes as “one of the most globally recognised healthcare platforms in the world.” Its evolution, he added, has tracked Dubai’s own development from regional trading centre to international nexus for business, logistics and innovation.

“Over the past five decades, WHX has evolved in line with the extraordinary growth of Dubai itself,” Hall says. “What started as a regional exhibition is now a truly international meeting point that connects healthcare leaders, innovators, policymakers and investors from around the globe.”

A new venue, a larger ambition

The 2026 edition of WHX marks a significant turning point, with the event moving to the Dubai Exhibition Centre in Expo City Dubai for the first time. For Hall, the venue shift reflects both the scale the event has reached and the city’s broader ambitions as a healthcare hub.

“We are incredibly excited to host WHX at the Dubai Exhibition Centre and to be among the first major events to inaugurate this spectacular new venue,” he says. “It offers a step-change in what we can deliver, from easier transport access and beautifully landscaped surroundings, to modern, flowing exhibition halls that significantly enhance the visitor experience.”

The move also solves a long-standing constraint. “Most importantly, this move enables something truly meaningful for the global healthcare industry: the reunion of WHX with WHX Labs, formerly Medlab,” Hall says. Space limitations at the Dubai World Trade Centre had forced the two events to operate separately for nearly a decade.

“For the past nine years, the two shows have had to operate separately because of space constraints at DWTC,” he says. “The scale of DEC finally allows us to bring the ecosystem back together.” In 2026, the organisers will operate a dual-venue format, with WHX hosted at DEC in the south of the city and WHX Labs remaining at DWTC in the north. “This effectively connects both sides of Dubai and reflects the scale and ambition of the global healthcare market today,” Hall says.

“With more than 235,000 professional visits and over 4,300 exhibitors expected, WHX 2026 will convene the global healthcare community at an unprecedented scale,” Hall says. “It marks a pivotal moment in the evolution of the event and reinforces both WHX’s growth and Dubai’s position as a leading global healthcare and innovation hub.”

Spotlight on biotech and life sciences

One of the most notable additions to the 2026 edition is a dedicated Biotech & Life Sciences Zone, reflecting the rapid expansion of these sectors across the GCC. Hall says the move aligns closely with national healthcare strategies in the UAE and Saudi Arabia.

“The launch of a dedicated Biotech & Life Sciences Zone reflects both the scale of opportunity in this sector and the strategic direction of healthcare development across the GCC,” he says.

Global and regional market dynamics support that focus. “Globally, the biotechnology market is on track to exceed $4tn by 2035, while the GCC market alone is expected to reach $2.6bn by 2028, led by the UAE and Saudi Arabia,” Hall says.

He pointed to growing investment in localised research and development across genomics, oncology, rare diseases and synthetic biology, alongside a shift from discovery to commercialisation. “We are also seeing a shift from discovery to commercialisation, with greater cross-border collaboration and increasing interest from global investors and partners,” he says.

By carving out a dedicated platform, WHX aims to accelerate this transition. “By creating this dedicated zone, WHX is providing a powerful platform for regional and international stakeholders to access emerging markets, build strategic partnerships, attract capital and accelerate the translation of science into scalable healthcare solutions,” Hall says.

Diagnostics and laboratory science at city scale

The integration of WHX Labs alongside WHX transforms the event from a single exhibition into a city-wide healthcare platform. For Hall, the scale of that integration is unprecedented.

“For the first time, more than 270,000 professional visits from 180 countries will converge in Dubai, creating an unprecedented concentration of global expertise, innovation and decision-making in a single city,” he says.

This density, Hall argues, changes the nature of participation. “Participants can engage across the full healthcare value chain – from diagnostics and laboratory science to clinical care and data-driven innovation – in a highly connected, cross-disciplinary environment,” he says.

The dual-event format enables laboratory specialists, clinicians, manufacturers and innovators to interact directly, mirroring how healthcare systems themselves are becoming more integrated. “The dual-event format maximises visibility and market access, accelerates deal-making, and amplifies knowledge exchange,” Hall says.

Beyond the exhibition floor, Hall emphasises that content remains central to WHX’s value proposition. “At WHX, content is at the heart of the experience,” he says. The 2026 programme will be delivered across three flagship stages, each aligned to a different dimension of healthcare transformation. “The Future X Stage will spotlight disruptive ideas and scalable innovation,” Hall says, bringing together founders, venture capitalists, digital health pioneers and healthcare institutions.

The Frontiers Stage will focus on scientific and clinical breakthroughs, “covering biotechnology, oncology, women’s health, wellness and longevity – from precision medicine and regenerative therapies to next-generation diagnostics and data-driven care models,” he says.

Meanwhile, the Visionary Stage will convene policymakers, executives and investors to address leadership, capital allocation, AI adoption, governance, ESG and advancing women in leadership. “Connecting strategy with real-world impact,” Hall says, is the goal. Complementing the stages, the new WHX Deep Dive Series will offer executive masterclasses and bootcamps, while six CME-accredited conferences will deliver specialty-specific clinical education. “Together, these initiatives reinforce WHX as a truly global platform for knowledge, innovation, and collaboration,” Hall says.

Anchoring a global network

WHX is part of a broader World Health Expo network spanning Asia, Africa and the Americas. Hall describes the Dubai edition as a cornerstone of that ecosystem.

“WHX is a cornerstone of the global World Health Expo network, linking the Middle East to a wider ecosystem of healthcare innovation and collaboration,” he says. Its scale gives regional stakeholders access to global markets while offering international participants entry into one of the fastest-growing healthcare regions.

For Informa, the event underscores a long-term commitment to the Middle East. “The region’s dynamic mix of healthcare sectors aligns perfectly with our mission to create platforms that drive innovation, investment, and knowledge exchange on a global scale,” Hall says.

Strategic partnerships remain central to WHX’s success, and Hall highlights the depth of government and industry support behind the 2026 edition. “Strategic partnerships are at the heart of WHX’s success,” he says.

Key government partners include the UAE Ministry of Health and Prevention, Dubai Health Authority, Department of Health – Abu Dhabi, and Sharjah Health Authority, alongside Dubai Health, Dubai Healthcare City Authority, Emirates Health Services, the Emirates Council for Integrative Medicine, and the Emirates Drug Establishment. On the industry side, global and regional leaders such as GE Healthcare, Siemens Healthineers, Philips, Canon, United Imaging, American Hospital in Dubai, Saudi German Health, Almoosa Health Group and Al Khayyat Investments will feature prominently.

“Together, these partnerships strengthen WHX’s mission as a marketplace for healthcare innovation, investment, and long-term collaboration,” Hall says.

Dubai’s advantage as a global connector

For Hall, the reason WHX continues to flourish in Dubai is ultimately geographic, infrastructural and strategic. “Dubai’s success as a host city comes from its unique position as a true nexus between East and West,” he says.

Its connectivity places two-thirds of the world’s population within an eight-hour flight. “This connectivity allows the city to link established Western markets with some of the fastest-growing healthcare economies in Asia, Africa, and the Middle East,” Hall says.

World-class infrastructure completes the equation. “Venues like the Dubai Exhibition Centre and Dubai World Trade Centre are purpose-built to deliver large-scale, immersive, technology-driven experiences,” he says.

As WHX enters its next half-century, the message from its organisers is clear: the event is no longer just a trade show. It is a global healthcare marketplace, a policy forum, an investment platform and a reflection of Dubai’s role in shaping the future of healthcare worldwide.